Literature DB >> 25927430

Association of DRD3, COMT, and SLC6A4 Gene Polymorphisms with Type 2 Diabetes in Southern Chinese: A Hospital-Based Case-Control Study.

Liangchang Xiu1, Meihua Lin1, Weiwei Liu1, Danli Kong1, Zhenghui Liu1, Yang Zhang1, Ping Ouyang1, Yan Liang2, Shouqiang Zhong2, Can Chen3, Xin Jin4, Xuejin Fan5, Jiheng Qin1, Xiaolei Zhao1, Shaoqi Rao1, Yuanlin Ding1.   

Abstract

AIM: The aim of this study was to assess the associations of six single nucleotide polymorphisms (SNPs) of three genes (DRD3, COMT, and SCL6A4) with type 2 diabetes mellitus (T2DM) in Southern Chinese. SUBJECTS AND METHODS: Five hundred ninety-five cases with T2DM and 725 healthy controls of Han origin were recruited from six hospitals in Guangdong Province, Southern China. Fasting serum concentrations of markers of interest (total cholesterol, triglyceride, plasma glucose, etc.) were measured in hospitals. SNP genotyping was performed using a custom-by-design 2-×48-Plex SNPscan™ kit (Genesky Biotechnologies Inc., Shanghai, China). Single-point SNP analysis, haplotype analysis, and SNP-SNP interactions were carried out.
RESULTS: SNP rs4646312 in COMT achieved statistical significance in both allelic association and genotypic association and even after adjusting covariates (odds ratio [OR]=1.26; 95% confidence interval [CI], 1.04-1.53; P=0.021). Two haplotypes consisting of rs4646312 and rs4680 were also significantly associated with T2DM, of which C-G was a protective haplotype for T2DM (OR=0.83; 95% CI, 0.70-0.98; P=0.029), whereas T-A was a risk one (OR=1.23, 95% CI, 1.03-1.46; P=0.022). Interaction analysis identified a significant epistatic effect between rs4680 in COMT and rs2066713 in SCL6A4 after adjusting for covariates (OR=3.59, 95% CI, 1.72-7.48; P=0.001 for dominant-dominant model). However, only the interaction between rs4680 and rs2066713 was significant, and haplotype T-A showed a marginally increased risk after Bonferroni correction.
CONCLUSIONS: The genetic polymorphisms in COMT and SCL6A4 confer significant effects in joint actions to T2DM in Southern Chinese.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25927430     DOI: 10.1089/dia.2014.0344

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  14 in total

Review 1.  Pharmacogenomics in type 2 diabetes: oral antidiabetic drugs.

Authors:  M A Daniels; C Kan; D M Willmes; K Ismail; F Pistrosch; D Hopkins; G Mingrone; S R Bornstein; A L Birkenfeld
Journal:  Pharmacogenomics J       Date:  2016-07-19       Impact factor: 3.550

2.  Systems pharmacogenomics - gene, disease, drug and placebo interactions: a case study in COMT.

Authors:  Kathryn T Hall; Joseph Loscalzo; Ted J Kaptchuk
Journal:  Pharmacogenomics       Date:  2019-05       Impact factor: 2.533

3.  Association study of the PLXNA4 gene with the risk of Alzheimer's disease.

Authors:  Hui Wang; Fu-Rong Sun; Lin Tan; Hui-Fu Wang; Wei Zhang; Zi-Xuan Wang; Teng Jiang; Jin-Tai Yu; Lan Tan
Journal:  Ann Transl Med       Date:  2016-03

4.  Association of DISC1 Polymorphisms with Late-Onset Alzheimer's Disease in Northern Han Chinese.

Authors:  Xiao-Yan Zhang; Hui-Fu Wang; Meng-Shan Tan; Yu Wan; Ling-Li Kong; Zhan-Jie Zheng; Chen-Chen Tan; Wei Zhang; Zi-Xuan Wang; Lin Tan; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-03-29       Impact factor: 5.590

5.  Catechol-O-methyltransferase association with hemoglobin A1c.

Authors:  Kenneth J Mukamal; Kathryn T Hall; Kathleen A Jablonski; Ling Chen; Maegan Harden; Benjamin R Tolkin; Ted J Kaptchuk; George A Bray; Paul M Ridker; Jose C Florez; Daniel I Chasman
Journal:  Metabolism       Date:  2016-04-14       Impact factor: 8.694

Review 6.  Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.

Authors:  Yutaka Mizuki; Shinji Sakamoto; Yuko Okahisa; Yuji Yada; Nozomu Hashimoto; Manabu Takaki; Norihito Yamada
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

7.  FERMT2 rs17125944 polymorphism with Alzheimer's disease risk: a replication and meta-analysis.

Authors:  Qiu-Yue Zhang; Hui-Fu Wang; Zhan-Jie Zheng; Ling-Li Kong; Meng-Shan Tan; Chen-Chen Tan; Wei Zhang; Zi-Xuan Wang; Lin Tan; Jin-Tai Yu; Lan Tan
Journal:  Oncotarget       Date:  2016-06-28

8.  The influence of dopamine-beta-hydroxylase and catechol O-methyltransferase gene polymorphism on the efficacy of insulin detemir therapy in patients with type 2 diabetes mellitus.

Authors:  Nela Pivac; Fran Borovecki; Tomislav Bozek; Antonela Blazekovic; Matea Nikolac Perkovic; Kristina Gotovac Jercic; Aleksandra Sustar; Lea Smircic-Duvnjak; Tiago F Outeiro
Journal:  Diabetol Metab Syndr       Date:  2017-12-04       Impact factor: 3.320

9.  Chemical genetic-based phenotypic screen reveals novel regulators of gluconeogenesis in human primary hepatocytes.

Authors:  Haixia Zou; Qian Liu; Li Meng; Jingye Zhou; Chenxiao Da; Xikun Wu; Lichun Jiang; Jianyong Shou; Haiqing Hua
Journal:  NPJ Genom Med       Date:  2018-08-15       Impact factor: 8.617

Review 10.  AMP-Activated Protein (AMPK) in Pathophysiology of Pregnancy Complications.

Authors:  Asako Kumagai; Atsuo Itakura; Daisuke Koya; Keizo Kanasaki
Journal:  Int J Mol Sci       Date:  2018-10-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.